Page last updated: 2024-10-24

carisoprodol and Anemia, Hemolytic

carisoprodol has been researched along with Anemia, Hemolytic in 1 studies

Carisoprodol: A centrally acting skeletal muscle relaxant whose mechanism of action is not completely understood but may be related to its sedative actions. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1202)
carisoprodol : A carbamate ester that is the mono-N-isopropyl derivative of meprobamate (which is a significant metabolite). Carisoprodol interrupts neuronal communication within the reticular formation and spinal cord, resulting in sedation and alteration in pain perception. It is used as a muscle relaxant in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm.

Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cayanis, E1
Gomperts, ED1
Balinsky, D1
Disler, P1
Myers, A1

Other Studies

1 other study available for carisoprodol and Anemia, Hemolytic

ArticleYear
G6PD hillbrow: a new variant of glucose-6-phosphate dehydrogenase associated with drug-induced haemolytic anaemia.
    British journal of haematology, 1975, Volume: 30, Issue:3

    Topics: Acetaminophen; Adult; Anemia, Hemolytic; Caffeine; Carisoprodol; Chlormezanone; Diclofenac; Drug Com

1975